These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 7352712

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Sensitivity of the causative agent of tularemia to antibiotics].
    Kudelina RI.
    Antibiotiki; 1978 Aug; 23(8):710-4. PubMed ID: 686695
    [Abstract] [Full Text] [Related]

  • 24. [Meningitis caused by Francisella Tularensis].
    Hakola K, Savola J.
    Duodecim; 1996 Aug; 112(14):1300-2. PubMed ID: 10596102
    [No Abstract] [Full Text] [Related]

  • 25. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals.
    Ikäheimo I, Syrjälä H, Karhukorpi J, Schildt R, Koskela M.
    J Antimicrob Chemother; 2000 Aug; 46(2):287-90. PubMed ID: 10933655
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Case report: a case of tularemia with delayed diagnosis].
    Hatipoglu CA, Bayiz U, Firat SK, Erdinç FS, Tülek N, Gedikoglu S.
    Mikrobiyol Bul; 2005 Jan; 39(1):89-94. PubMed ID: 15900842
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Treatment Outcome of Severe Respiratory Type B Tularemia Using Fluoroquinolones.
    Widerström M, Mörtberg S, Magnusson M, Fjällström P, Johansson AF.
    Clin Infect Dis; 2024 Jan 31; 78(Suppl 1):S38-S46. PubMed ID: 38294118
    [Abstract] [Full Text] [Related]

  • 30. Treatment of tularemia with fluoroquinolones: two cases and review.
    Limaye AP, Hooper CJ.
    Clin Infect Dis; 1999 Oct 31; 29(4):922-4. PubMed ID: 10589911
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species.
    Georgi E, Schacht E, Scholz HC, Splettstoesser WD.
    J Antimicrob Chemother; 2012 Oct 31; 67(10):2429-33. PubMed ID: 22763567
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Streptomycin studies in tularemia; the effect of streptothricin and streptomycin on Bacterium tularense in vitro and in vivo (mouse).
    CHAPMAN SS, DOWNS CM.
    J Infect Dis; 1949 Oct 31; 85(1):25-38. PubMed ID: 18132368
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A case of oculoglandular tularemia resistant to medical treatment.
    Kosker M, Sener D, Kilic O, Akil F, Yilmaz M, Ozturk O, Cokugras H, Camcioglu Y, Akcakaya N.
    Scand J Infect Dis; 2013 Sep 31; 45(9):725-7. PubMed ID: 23746340
    [Abstract] [Full Text] [Related]

  • 38. [Francisella tularensis and tularemia in Turkey].
    Gürcan S.
    Mikrobiyol Bul; 2007 Oct 31; 41(4):621-36. PubMed ID: 18173084
    [Abstract] [Full Text] [Related]

  • 39. Broth microdilution susceptibility testing of Francisella tularensis: quality control limits for nine antimicrobial agents and three standard quality control strains.
    Brown SD, Krisher K, Traczewski MM.
    J Clin Microbiol; 2004 Dec 31; 42(12):5877-80. PubMed ID: 15583330
    [Abstract] [Full Text] [Related]

  • 40. Treatment of tularemia in patient with chronic graft-versus-host disease.
    Weile J, Seibold E, Knabbe C, Kaufmann M, Splettstoesser W.
    Emerg Infect Dis; 2013 May 31; 19(5):771-3. PubMed ID: 23647853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.